Ugur. Sahin, et.al., Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development., Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, 14

http://rdf.ncbi.nlm.nih.gov/pubmed/19047087

Ugur. Sahin, et.al., Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development., Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, 14

http://rdf.ncbi.nlm.nih.gov/pubmed/

トランスクリプトームデータ

http://rdf.ncbi.nlm.nih.gov/pubmed/

• CD21300
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD21300